Medpace SEC filings
Filter: All · 8-K · 10-Q · 10-K · Form 4
Results of operations and financial condition · Other events · Financial statements and exhibits
AI summary, unreviewedMedpace Holdings (MEDP) Q3 2026 Revenue Rises 8.5% to $716.0 Million, Diluted EPS $4.84 vs $3.86; Guidance Given; $1.0 Billion Buyback Authorized